| 注册
首页|期刊导航|时珍国医国药|人参皂苷纳米递送系统抗骨关节炎的应用进展

人参皂苷纳米递送系统抗骨关节炎的应用进展

郭天赐 王平 王继达 刘爱峰

时珍国医国药2026,Vol.37Issue(13):2578-2585,8.
✕
时珍国医国药2026,Vol.37Issue(13):2578-2585,8.DOI:10.70976/j.1008-0805.SZGYGY-2026-1325

人参皂苷纳米递送系统抗骨关节炎的应用进展

Recent advances in ginsenoside nanodelivery systems for osteoarthritis treatment

郭天赐 1王平 1王继达 1刘爱峰1

作者信息

  • 1. 天津中医药大学第一附属医院骨伤科,天津 300381||中医国家临床医学研究中心,天津 300381
  • 折叠

摘要

Abstract

Through systematic retrieval of domestic and international literature,combined with practical application of nanopharmaceu-tical technology and based on pharmacodynamic evaluation,this review systematically summarizes the synergistic mechanisms and safety profiles of ginsenoside nanodelivery systems in osteoarthritis(OA)treatment.Nanodelivery systems significantly improve ginsen-oside bioavailability by enhancing targeted delivery,prolonging joint retention,and increasing cartilage permeability.Future directions include AI-optimized carrier design and establishment of safety evaluation protocols specific to traditional Chinese medicine nan prepara-tions,facilitating clinical translation for improved OA management.

关键词

骨关节炎/人参皂苷/纳米递送系统/脂质体/纳米粒

Key words

Osteoarthritis/Ginsenoside/Nanodelivery systems/Liposomes/Nanoparticles

分类

医药卫生

引用本文复制引用

郭天赐,王平,王继达,刘爱峰..人参皂苷纳米递送系统抗骨关节炎的应用进展[J].时珍国医国药,2026,37(13):2578-2585,8.

基金项目

国家自然科学基金(82474538,81873316) (82474538,81873316)

天津市津门医学英才项目(TJSJMYXYC-D2-028) (TJSJMYXYC-D2-028)

时珍国医国药

1008-0805

访问量0
|
下载量0
段落导航相关论文